Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine

Published:2022-03 Issue: Volume:6 Page:107-108
ISSN:2666-3287
Container-title:JAAD International
language:en
Short-container-title:JAAD International

Author:

Wu Xiaotian^ORCID,Lim Joel Hua Liang,Lee Joyce Siong See,Chio Martin Tze-Wei

Publisher

Elsevier BV

Subject

General Medicine

Reference5 articles.

1. Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum;Labunski;Acta Derm Venereol,2001

2. Sahin U, Muik A, Derhovanessian E, et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature. 2020;586(7830):594-599. Published correction appears in Nature. 2021;590(7844):E17. https://doi.org/10.1038/s41586-020-2814-7

3. TNF-alpha in tuberculosis: a cytokine with a split personality;Mootoo;Inflamm Allergy Drug Targets,2009

4. POS0422 Panniculitis as a manifestation of an autoimmune/autoinflammatory disease;Egorova;Ann Rheum Dis,2021

5. The ASIA syndrome: basic concepts;Watad;Mediterr J Rheumatol,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythema nodosum following COVID‐19 vaccination: A case report and literature review;JEADV Clinical Practice;2023-06-14

2. Erythema nodosum after COVID ‐19 vaccine: Report of two pediatric cases;Pediatric Dermatology;2022-11-30

3. Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review;Journal of Autoimmunity;2022-10

4. Erythema nodosum associated with COVID19 infection: A pediatric case report and review of the literature;Pediatric Dermatology;2022-08-02

5. This Month in JAAD International: August 2022: Cutaneous reactions to COVID-19 messenger RNA booster dose vaccination;Journal of the American Academy of Dermatology;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3